Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide, and is characterized by the progressive loss of dopaminergic neurons in the substantia nigra (SN). [1] [2] [3] The clinical symptoms of PD mainly include rest tremors, rigidity, bradykinesia and postural abnormalities. 4, 5) At present, a number of genetic factors such as Parkin, a-synuclein, DJ-1, PINK1 and LRRK2, as well as environmental factors such as exposure to pesticides, neurotoxins and heavy metals, have been considered to contribute to the onset of PD.
). 10) One of the hallmarks of PD is the presence of asynuclein inclusions, termed Lewy bodies, in the dopaminergic neurons of SN and other brain regions such as cortex and basal forebrain nuclei. a-Synuclein is generally thought to play an important role in synaptic plasticity and to function under normal expression, but it has neuropathological effects when overexpressed or mutated and induces the formation of Lewy bodies. 11, 12) Protocatechuic acid (PAc) (Fig. 1) is a water-soluble monomeric phenolic acid with strong free radical scavenging effects. 13) The neuroprotective effects of PAc have previously been reported. 14) However, little is known about the effects of PAc on tyrosine hydroxylase (TH) and oligomerization of asynuclein in rat pheochromocytoma (PC12) cells treated with MPP ϩ . The aim of this study was to investigate the effects of PAc on these aspects.
MATERIALS AND METHODS
Materials PAc (purity Ͼ99%) was purchased from the National Institute for the Control of Pharmaceutical and Biological Products (China). F12K cell culture medium was purchased from Invitrogen (Carlsbad, CA, U.S.A.). Donor equine serum was purchased from Hyclone (Logan, UT, U.S.A.) and fetal bovine serum from Si-ji-qing (Hangzhou, China). MPP ϩ , 3-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and hoechst 33342 were purchased from Sigma (St. Louis, MO, U.S.A.). Rabbit TH monoclonal antibody was purchased from Chemicon (Temecula, CA, U.S.A.). The bicinchoninic acid (BCA) protein assay kit was purchased from Perice (Rockford, IL, U.S.A.). Mouse asynuclein monoclonal antibody and rabbit b-actin polyclonal antibody were purchased from Santa Cruz (Santa Cruz, CA, U.S.A.). Fluoresceine isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobin G (IgG) and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG were purchased from Zhong-shan Goldenbridge (Beijing, China). HRP-conjugated goat anti-rabbit IgG was purchased from Ding-guo (Beijing, China).
Cell Culture The PC12 cell line was purchased from the Shanghai Cell Bank, Chinese Academy of Sciences and grown in F12K medium with glutamine supplemented with 15% donor equine serum and 2.5% fetal bovine serum at 37°C in a humidified 5% CO 2 cell precipitates were fixed with glutaraldehyde, post-fixed with osmium tetroxide, dehydrated through a graded alcohol series, soaked in epoxy resin and acetone and embedded into epoxy resin. Ultra-thin sections were then cut and stained with uranyl acetate and lead citrate and examined under a JEM-100 transmission electron microscope (Jeol, Japan). TH Immunofluorescence Cells were pre-treated with PAc (0.33 mM, 0.65 mM, 1.30 mM) for 6 h, then 1 mM MPP ϩ was added and the incubation continued for 24 h. After treatment, cells were fixed with 4% paraformaldehyde solution for 30 min, penetrated with 0.3% Triton X-100 solution for 5 min, blocked with 10% goat serum solution for 30 min, incubated with rabbit monoclonal TH antibody (1 : 300) overnight, immuno-reacted with FITC-conjugated goat antirabbit secondary antibody for 1 h, stained with hoechst 33342 for 10 min and visualized under a TCS spII confocal laser-scanning microscope (CLSM) (Leica, Germany).
a a-Synuclein Western Blot Cells were pre-treated with PAc (0.33 mM, 0.65 mM, 1.30 mM) for 6 h, then 1 mM MPP ϩ was added and the incubation continued for 24 h. After treatment, cell precipitates were lysed and centrifuged. Supernatants were quantified and run on a 12.5% sodium dodecyl sulfate (SDS) polyacrylamide gel. The separated proteins were blotted onto a poly(vinylidene fluoride) (PVDF) membrane and processed for immunodetection. An a-synuclein monoclonal antibody was used as the primary antibody (1 : 1000) and HRP-conjugated IgG as the secondary antibody. b-Actin was used as an internal standard. An enhanced chemiluminescence detection system was applied to detect the target proteins. The results of Western blot were analyzed and quantified by Quantity One software (Bio-Rad, U.S.A.).
Statistical Analysis Data are expressed as meanϮS.D. of three independent experiments. Statistical analysis was performed using Student's t-test and one-way analysis of variance (one-way ANOVA) by SPSS 13.0 software and differences were considered to be statistically significant when pϽ0.05. ϩ treatment resulted in apoptosis of cells, characterized by chromatin condensation and fragmentation and mitochondria engorgement. Cells pre-treated with PAc (1.30 mM) before MPP ϩ treatment, however, exhibited a relatively normal cellular morphology characterized by chromatin dispersion and normal mitochondria (Fig. 3) .
RESULTS

PAc Inhibited the Cytotoxicity in PC12 Cells
PAc Inhibited the Reduction of TH Expression in PC12 Cells Treated with MPP
؉
The dopaminergic neuron phenotype of PC12 cells was identified by examining the expression of TH using immunofluorescence. MPP ϩ treatment resulted in neurites decurtation and decreased fluorescence intensity for TH of cells. However, cells pre-treated with PAc (0.33 mM, 0.65 mM, 1.30 mM) before MPP ϩ treatment, displayed elongated neurites and increased fluorescence intensity for TH. Green fluorescence represents the expression of TH and blue fluorescence represents the location of nuclei (Fig. 4) .
PAc Inhibited the Oligomerization of a a-Synuclein in (Fig. 5) .
DISCUSSION
In the present study, we have confirmed that PAc has neuroprotective effects on PC12 cells treated with MPP ϩ by MTT assay, TEM morphology and TH immunofluorescence.
Considerable evidences have shown that dopaminergic neurons of the SN in PD patients show characteristics of apoptosis, including nuclear condensation, chromatin fragmentation, and formation of apoptotic-like bodies.
1,2) MPP ϩ has also been found to cause apoptosis in dopaminergic PC12 cells. 15) TEM results indicated that PAc inhibits the chromatin condensation and margination and mitochondria engorgement, typical features of apoptosis, in PC12 cells treated with MPP ϩ . Dopamine (DA) is a main neurotransmitter of dopaminergic neurons in SN-striatum and it is synthesized from tyrosine by the catalysis of TH, the rate-limiting enzyme of DA production process. Naturally, the expression of TH in SN becomes a parameter reflecting the activity of dopaminergic neurons. It has reported that the dopaminergic neuron phenotype of PC12 cells was identified by examining the expression of TH using immunofluorescence. 16) Our results demonstrated that PAc can inhibit the reduction of TH expression in PC12 cells induced by MPP ϩ . To reveal the possible mechanism by which PAc inhibits the neurotoxicity in PC12 cells induced by MPP ϩ , a-synuclein was detected by Western blot analysis. The a-synuclein aggregation into oligomers, fibrils, up to Lewy bodies affects neuronal viability, having a causal role in the development of PD, and the prevention of these abnormal changes has become the focus of new PD therapeutic efforts. 11, 12) According to these literatures, when over expressed or mutated by outer stimuluses such as MPTP/MPP ϩ , the monomeric asynuclein is easily marched oligomerization forming into oligomers (57 kDa). Xu and colleagues 17) have reported that MPP ϩ can increase the expression of oligomeric a-synuclein (57 kDa) in PC12 cells. Our Western blot assays showed that PAc significantly inhibits the reduction of monomeric asynuclein (19 kDa) expression and the augmentation of oligomeric a-synuclein (57 kDa) expression in MPP ϩ -treated PC12 cells. For these reasons mentioned above, we deduce that PAc inhibits the abnormal oligomerization of a-synuclein in PC12 cells induced by MPP ϩ probably through inhibiting the over expression or mutation and stabilizing the physiological level of a-synuclein. It has been reported that the inhibition of TH in dopaminergic cells are considered to be tightly linked with dopaminergic cell death caused by the abnormal changes in a-synuclein. 18, 19) In our experiments, we detected that PAc inhibits the reduction of TH expression in MPP ϩ -treated PC12 cells. Therefore, the inhibitory effects of PAc on damages in PC12 cells treated with MPP ϩ detected by MTT assay, TEM morphology and TH immunofluorescene are possibly related to the suppression of the abnormal oligomerization of a-synuclein. The significant inhibitory effect of PAc on the oligomerization of a-synuclein indicates that this could be one of the main mechanisms for neuroprotective effects of PAc on MPP ϩ -induced toxicity in PC12 cells. Our next research will focus on clarifying the precise mechanisms that the neuroprotective effects of PAc on PC12 cells induced by MPP ϩ are related to the inhibition of the oligomerization of a-synuclein.
In summary, the results of the present study indicate that PAc can protect cultured PC12 cells against damage induced by MPP ϩ . We demonstrate, for the first time, that the neuroprotective effects of PAc, at least in part, are related to the suppression of the oligomerization of a-synuclein. 
